| abstract |
Patients suffering from inflammatory bowel diseasensuch as Crohn's disease or ulcerative colitis arentreated either orally or intravenously with methylolntransfer agents, such as taurolidine and/or taurultam.nThese agents can be used in combination with other drugsnthereby allowing the use of smaller amounts of otherndrugs and limiting unwanted side effects. |